Impax

                   

Impax wins final FDA approval for generic depression drug

pharmiweb.co.uk
2 hrs ago
        

Dec 01, 2008 (Datamonitor via COMTEX) -- -- Impax Laboratories, a specialty pharmaceutical company, has announced that the FDA has granted final approval of the company's abbreviated new drug application for a generic version...

add comment

RPT-PREVIEW-UK climate change body to unveil emissions cut plans

finanznachrichten.de
7 hrs ago 269 related
        

By Peter Griffiths LONDON, Nov 28 (Reuters) - British Prime Minister Gordon Brown set up the committee to advise ministers on what his government describes as the world's greatest environmental challenge. Energy and Climate...

add comment

Consumer Electronics and Casual Apparel Are Top Ticket Items on Black Friday

marketwire.com
4 hrs ago 2 related
        

NearbyNow Reports Product Demand Information for Hundreds of Local Shopping Areas Across the US for First Official 2008 Holiday Shopping Weekend MOUNTAIN VIEW, CA--(Marketwire - Black Friday and the following Saturday showed...

add comment
                   

Sun loses $3-bn revenue potential from US

business-standard.com
20 mins ago
        

Osmotica pips Indian firm to get FDA nod for selling anti-depressant. Sun Pharmaceutical Industries, India's largest drug maker by market value, has lost out on a $3-billion revenue potential from the US market after a rival...

add comment
                   

IMPAX Receives Final FDA Approval For Generic Wellbutrin(R) XL 150 Mg

medicalnewstoday.com
4 hrs ago
        

IMPAX Laboratories, Inc. announced that the U.S. Food and Drug Administration (FDA) granted final approval of the Company's Abbreviated New Drug Application (ANDA) for a generic version of Wellbutrin® XL 150 mg Extended-release...

add comment

Health Cost Containment Index: Expanding Into India, Impax Labs Set to Re-List

istockanalyst.com
27-Nov-2008 2 related
        

The ETF Innovators (ETFI) Global Healthcare Cost Containment Index profiled in the accompanying table is updated and expanded to include more companies from my recent Analysis of Generic Drug Companies from India. The index is...

add comment
edubourse.com: Agfa HealthCare to display IMPAX® Scheduling solution at RSNA 2008 edubourse.com

Agfa HealthCare to display IMPAX™ Data Center at RSNA 2008

webwire.com
23-Nov-2008 1 related
        

Leading vendor neutral image infrastructure solution consolidates data from disparate systems into a single point of storage - - (RSNA Booth #4800) Agfa HealthCare, a leading provider of IT-enabled cli... [WebWire - Monday,...

add comment

UPDATE 1-MOVES-KKR, Citigroup, Evolution Securities, Impax

finanznachrichten.de
20-Nov-2008 1 related
        

KOHLBERG KRAVIS ROBERTS&CO (KKR) Citigroup's South Asia Chief Executive Sanjay Nayar has quit to run private-equity firm Kohlberg Kravis Roberts&Co's new Indian unit, leaving the struggling bank after a 23-year career. Nayar...

add comment

UPDATE - MOVES-KKR, Citigroup, Evolution Securities, Impax (at Reuters)

yahoo.com
20-Nov-2008 39 related
        

KOHLBERG KRAVIS ROBERTS & CO (KKR) [KKR.UL] ) South Asia Chief Executive Sanjay Nayar has quit to run private-equity firm Kohlberg Kravis Roberts & Co's new Indian unit, leaving the struggling bank after a 23-year career. Nayar...

add comment

Lilly sues generic drug makers over Cymbalta

pharmiweb.co.uk
19-Nov-2008 4 related
        

Pharmaceutical company Eli Lilly is suing generic drug companies for infringing its patents for the anti-depressant drug Cymbalta (duloxetine). Lilly filed suit against Impax Laboratories, Cobalt Laboratories, Wockhardt and...

add comment
1 2 next